Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review

Background People in underserved groups have higher rates of tuberculosis (TB) and poorer treatment outcomes compared with people with no social risk factors.Objectives This scoping review aimed to identify interventions that improve TB treatment adherence or completion rates.Eligibility criteria St...

Full description

Saved in:
Bibliographic Details
Main Authors: Janine Dretzke, David J Moore, Anjana Roy, Lauren Ahyow, Carla Hobart, Anamika Basu, Ahimza Nagasivam, Roger Gajraj
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e080827.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717271477354496
author Janine Dretzke
David J Moore
Anjana Roy
Lauren Ahyow
Carla Hobart
Anamika Basu
Ahimza Nagasivam
Roger Gajraj
author_facet Janine Dretzke
David J Moore
Anjana Roy
Lauren Ahyow
Carla Hobart
Anamika Basu
Ahimza Nagasivam
Roger Gajraj
author_sort Janine Dretzke
collection DOAJ
description Background People in underserved groups have higher rates of tuberculosis (TB) and poorer treatment outcomes compared with people with no social risk factors.Objectives This scoping review aimed to identify interventions that improve TB treatment adherence or completion rates.Eligibility criteria Studies of any design focusing on interventions to improve adherence or completion of TB treatment in underserved populations in low incidence countries.Sources of evidence MEDLINE, Embase and Cochrane CENTRAL were searched (January 2015 to December 2023).Charting methods Piloted data extraction forms were used. Findings were tabulated and reported narratively. Formal risk of bias assessment or synthesis was not undertaken.Results 47 studies were identified. There was substantial heterogeneity in study design, population, intervention components, usual care and definition of completion rates. Most studies were in migrants or refugees, with fewer in populations with other risk factors (eg, homelessness, imprisonment or substance abuse). Based on controlled studies, there was limited evidence to suggest that shorter treatment regimens, video-observed therapy (compared with directly observed therapy), directly observed therapy (compared with self-administered treatment) and approaches that include tailored health or social support beyond TB treatment may lead to improved outcomes. This evidence is mostly observational and subject to confounding. There were no studies in Gypsy, Roma and Traveller populations, or individuals with mental health disorders and only one in sex workers. Barriers to treatment adherence included a lack of knowledge around TB, lack of general health or social support and side effects. Facilitators included health education, trusted relationships between patients and healthcare staff, social support and reduced treatment duration.Conclusions The evidence base is limited, and few controlled studies exist. Further high-quality research in well-defined underserved populations is needed to confirm the limited findings and inform policy and practice in TB management. Further qualitative research should include more people from underserved groups.
format Article
id doaj-art-6bc56edbcda8463d96a6b333bfc40c83
institution DOAJ
issn 2044-6055
language English
publishDate 2024-03-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-6bc56edbcda8463d96a6b333bfc40c832025-08-20T03:12:42ZengBMJ Publishing GroupBMJ Open2044-60552024-03-0114310.1136/bmjopen-2023-080827Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping reviewJanine Dretzke0David J Moore1Anjana Roy2Lauren Ahyow3Carla Hobart4Anamika Basu5Ahimza Nagasivam6Roger Gajraj71 Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK1 Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UKHealth Equity and Inclusion Health Division, UKHSA, London, UKUK Health Security Agency, London, UKUK Health Security Agency, London, UKUK Health Security Agency, London, UKUK Health Security Agency, London, UKUK Health Security Agency, London, UKBackground People in underserved groups have higher rates of tuberculosis (TB) and poorer treatment outcomes compared with people with no social risk factors.Objectives This scoping review aimed to identify interventions that improve TB treatment adherence or completion rates.Eligibility criteria Studies of any design focusing on interventions to improve adherence or completion of TB treatment in underserved populations in low incidence countries.Sources of evidence MEDLINE, Embase and Cochrane CENTRAL were searched (January 2015 to December 2023).Charting methods Piloted data extraction forms were used. Findings were tabulated and reported narratively. Formal risk of bias assessment or synthesis was not undertaken.Results 47 studies were identified. There was substantial heterogeneity in study design, population, intervention components, usual care and definition of completion rates. Most studies were in migrants or refugees, with fewer in populations with other risk factors (eg, homelessness, imprisonment or substance abuse). Based on controlled studies, there was limited evidence to suggest that shorter treatment regimens, video-observed therapy (compared with directly observed therapy), directly observed therapy (compared with self-administered treatment) and approaches that include tailored health or social support beyond TB treatment may lead to improved outcomes. This evidence is mostly observational and subject to confounding. There were no studies in Gypsy, Roma and Traveller populations, or individuals with mental health disorders and only one in sex workers. Barriers to treatment adherence included a lack of knowledge around TB, lack of general health or social support and side effects. Facilitators included health education, trusted relationships between patients and healthcare staff, social support and reduced treatment duration.Conclusions The evidence base is limited, and few controlled studies exist. Further high-quality research in well-defined underserved populations is needed to confirm the limited findings and inform policy and practice in TB management. Further qualitative research should include more people from underserved groups.https://bmjopen.bmj.com/content/14/3/e080827.full
spellingShingle Janine Dretzke
David J Moore
Anjana Roy
Lauren Ahyow
Carla Hobart
Anamika Basu
Ahimza Nagasivam
Roger Gajraj
Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
BMJ Open
title Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
title_full Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
title_fullStr Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
title_full_unstemmed Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
title_short Interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries: a scoping review
title_sort interventions to improve latent and active tuberculosis treatment completion rates in underserved groups in low incidence countries a scoping review
url https://bmjopen.bmj.com/content/14/3/e080827.full
work_keys_str_mv AT janinedretzke interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT davidjmoore interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT anjanaroy interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT laurenahyow interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT carlahobart interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT anamikabasu interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT ahimzanagasivam interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview
AT rogergajraj interventionstoimprovelatentandactivetuberculosistreatmentcompletionratesinunderservedgroupsinlowincidencecountriesascopingreview